MedTrace Logo

Multi-Drug Resistant Bacteria Carriage After Travel

NCT03477760 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2018-03-26

No results posted yet for this study

Summary

During one month, from 1st to 30th November 2016, all patients admitted in one of the medical Dpt of our Hospital (Internal Medicine Dpt, Endocrinology, ICU) will be screened for multi-drug resistant bacteria carriage (after written consent). They will answer to a questionnaire about previous travel in a foreign country during the previous year, hospitalization or not during this travel.

Conditions

  • Beta Lactam Resistant Bacterial Infection (Disorder)

Interventions

BIOLOGICAL

rectal swab for Multi-Drug resistant bacteria

A rectal swab will be performed at admission of patients to look for intestinal carriage of Multi-Drug resistant bacteria

Sponsors & Collaborators

  • Hopital Lariboisière

    lead OTHER

Principal Investigators

  • Pierre O Sellier, M.D., Ph.D. · Hopital Lariboisiere

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03477760 on ClinicalTrials.gov